GlaxoSmithKline Pulls Application For New Drug Use
Britain's GlaxoSmithKline pulls application to sell enlarged prostate drug for blocking cancer
01:21PM 11/23/09
Healthcare Stocks: Safe and Speculative
NEW YORK (TheStreet) -- Allos Therapeutics is the best speculative bet in the sector. Watch this video for the safest and biggest growth stock to add to your portfolio.
12:56PM 11/23/09
'Fast Money' Recap: Playing Defense
The trading panel discussed moves for a market that is shifting to the downside.
07:46PM 11/19/09
Moody's Gives Negative View On Pharma Credit
Moody's: credit ratings for drugmakers could be hurt as industry copes with expiring patents
01:15PM 11/19/09
U.S. Sees Low Demand for BioCryst Flu Drug
Peaking flu season could mean no need for further peramivir orders.
11:12AM 11/18/09
Drugmakers' Differences: Analyst's Toolkit
Pharmaceutical companies require their own metrics of evaluation. Sanofi, which looks strong in some ways, comes across as risky in others.
05:00AM 11/18/09
Vaccines On Horizon For AIDS, Alzheimer's, Herpes
'Golden era' could bring vaccines against AIDS, Alzheimer's and addictions within 5 years
01:48PM 11/17/09
Sprint, CombinatoRx: Early Volume Plays
Several stocks trading under $5 were poised to move on above-average volume during Monday's session.
09:04AM 11/16/09
FDA Delays Cadence Drug Review: BioBuzz
IV Acetaminophen review pushed back to February 2010.
08:24AM 11/13/09
Big Value in Valeant (RealMoney.com $)
I'm following the insiders here -- this pharma play has tons of upside.
02:30PM 11/11/09
Drug Industry Presses FDA To Allow More Online Ads
Drug industry presses FDA to allow branded ads on Google, Twitter, other Web sites
12:02PM 11/11/09
Glaxo, XenoPort Drug To Get Longer FDA Review
GlaxoSmithKline, XenoPort drug candidate gets extended FDA regulatory review
04:37PM 11/10/09
Doc Offers Top Hep C Drug Picks: BioBuzz
Vertex, InterMune, Pharmasset get positive reviews after recent Hep C meeting.
01:54PM 11/09/09
Xoma Waffles on Timing of Drug Partnership: BioBuzz
An expected deal for its diabetes drug may not happen until next year.
10:23AM 11/09/09



Connect with TheStreet